Sylvain Armando

The chemokine CXC4 and CC2 receptors form homo‐ and heterooligomers that can engage their signaling G‐protein effectors and βarrestin

L. Prézeau, J. Pin, N. Heveker, 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

A new inhibitor of the β-arrestin/AP2 endocytic complex reveals interplay between GPCR internalization and signalling

Philippe P Roux, D. Veprintsev, M. Bouvier, 2017, Nature Communications.

The experimental power of FR900359 to study Gq-regulated biological processes

H. Dohlman, C. Müller, M. Hesse, 2015, Nature Communications.

A Synthetic Biology Approach Reveals a CXCR4-G13-Rho Signaling Axis Driving Transendothelial Migration of Metastatic Breast Cancer Cells

Michel Bouvier, Hiroshi Yagi, J Silvio Gutkind, 2011, Science Signaling.

Multimerization of Staufen1 in live cells.

T. Duchaine, M. Bouvier, B. Breton, 2010, RNA.

Site-specific Phosphorylation of CXCR4 Is Dynamically Regulated by Multiple Kinases and Results in Differential Modulation of CXCR4 Signaling*

J. Benovic, O. Meucci, M. Bouvier, 2010, The Journal of Biological Chemistry.

Neurosphere-derived neural cells show region-specific behaviour in vitro

J. Hugnot, A. Lebrun, C. Ripoll, 2007, Neuroreport.

Discovery of a dual Ras and ARF6 inhibitor from a GPCR endocytosis screen

J. Selent, M. Bouvier, Y. Namkung, 2020, Nature Communications.

Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein

J. Benovic, M. Bouvier, V. Lukashova, 2013, Proceedings of the National Academy of Sciences.

Quantifying biased signaling in GPCRs using BRET-based biosensors.

D. Devost, Y. Namkung, S. Laporte, 2016, Methods.